We are live on
!
Find out more
SRNE
Sorrento Therapeutics, Inc.
SRNE
SRNE
Delisted
SRNE was delisted on the 22nd of February, 2023.
62 hedge funds and large institutions have $99.5M invested in Sorrento Therapeutics, Inc. in 2016 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 16 increasing their positions, 20 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
303% more call options, than puts
Call options by funds: $730K | Put options by funds: $181K
38% more capital invested
Capital invested by funds: $72M → $99.5M (+$27.5M)
0% more funds holding
Funds holding: 62 → 62 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 7
20% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 20
Holders
62
Holders Change
–
Holders Change %
0%
% of All Funds
1.65%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
7
Increased
16
Reduced
20
Closed
7
Calls
$730K
Puts
$181K
Net Calls
+$549K
Net Calls Change
+$387K
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.72M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.07M |
| 3 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$489K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$228K |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
+$198K |
